🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

EHC EHC

Company Profile ↓
$110.90
+2.00% 1Y
Mkt Cap$12.87B
P/E20.02
P/B5.28
52W High$126.46
52W Low$93.47
Book Value$21.01
EPS (TTM)$5.54

Company Overview

EHC (EHC) is a publicly traded company listed on with a market capitalization of $12.87B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 23.2%, reflecting efficient use of shareholder capital.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $5.94B (+10.5% YoY); net profit $566.20M.
  • Trailing 12 Months Year-on-year growth — revenue +10.5%, earnings +24.2%.
  • 5-Year Trend Long-term compounding — revenue CAGR 5.6%, profit CAGR 4.9%.

Growth & Price Performance

Compounded Sales Growth

5 Years:5.57%
1 Year:10.46%

Compounded Profit Growth

5 Years:4.87%
1 Year:24.25%

Stock Price Performance

1 Year:+2.00%
6 Months:+17.98%
3 Months:+5.66%
1 Month:+0.16%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 53% of range
$93.47 $126.46
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)52.88 · Neutral
Price Performance
1M+0.16%
3M+5.66%
6M+17.98%
1Y+2.00%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Strong return on equity of 23.2%.
  • Generates positive free cash flow.

CONS

  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
20.02
Industry PE
-
Forward P/E est.
16.11
PEG Ratio
-
Book Value
$21.01
Price to Book
5.28
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
5.57%
Profit 5Y
4.87%
Revenue (YoY)
10.46%
Earnings (YoY)
24.25%

Profitability & Returns

ROCE
8.63%
ROE
23.22%
ROA
7.99%
Profit Margin
9.54%
Op Margin
9.09%
Gross Margin
-
EPS (Latest Qtr)
$1.93
EPS (TTM)
$5.54

Balance Sheet & Liquidity

Debt/Equity
1.11
Quick Ratio
-
Current Ratio
1.08
Debt
$2.71B
Total Assets
$7.31B
Current Assets
$905.90M
Working Capital
$69.50M

Ownership

Promoter Holding
1.07%
Chg in Prom Hold
-
FII / Inst Holding
101.64%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$5.94B
EBITDA
-
Free Cash Flow
$141.00M
Operating Cash Flow
$705.80M
Shares Outstanding
116.04M
Gross Margin
-
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026
Revenue ------957.10M966.40M981.60M1.01B1.05B1.07B1.07B1.10B1.12B1.14B1.16B1.18B1.18B1.07B1.17B1.21B959.90M1.00B1.01B1.04B1.06B1.06B1.09B1.14B1.16B1.19B1.21B1.32B1.30B1.35B1.46B1.46B1.48B1.59B
Operating Income 121.20M135.50M144.20M150.20M148.20M145.50M147.10M141.30M145.20M144.70M150.00M157.30M154.50M93.40M167.10M152.60M151.20M141.20M159.30M85.20M151.10M168.30M143.00M146.80M141.40M128.40M131.50M128.60M127.50M151.90M----------
Net Income 50.70M47.00M58.00M62.60M61.70M65.30M66.80M63.00M65.90M75.40M83.80M91.80M88.60M28.10M102.30M91.20M97.60M67.60M87.00M33.50M77.70M86.00M107.30M113.30M100.00M91.60M87.50M48.70M45.40M89.40M87.70M91.40M85.30M112.50M114.10M108.20M151.50M142.10M126.50M194.50M
Diluted EPS 0.520.490.610.650.640.680.700.700.670.760.840.920.890.281.030.920.980.680.870.340.780.861.071.131.000.910.870.490.450.890.870.900.841.101.121.061.481.391.241.93

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue --------3.64B3.91B4.28B4.61B3.57B4.01B4.35B4.80B5.37B5.94B
Operating Income -------485.70M588.10M578.30M555.20M612.10M563.90M559.60M539.50M---
Net Income 252.40M94.80M899.00M208.70M185.00M323.60M222.00M183.10M247.60M271.10M292.30M358.70M284.20M412.20M271.00M352.00M455.70M566.20M
Diluted EPS 2.620.778.281.961.672.582.291.912.592.842.933.612.854.112.703.474.465.54

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --1.68B2.37B2.27B2.42B2.53B3.39B4.61B4.68B4.86B5.17B6.08B6.45B-5.64B6.10B6.53B7.09B
Current Assets ---------------717.20M841.80M886.90M905.90M
Cash & Equivalents -31.70M80.70M48.30M30.10M132.80M64.50M66.70M61.60M40.50M54.40M69.20M60.00M185.60M-21.80M69.10M85.40M72.20M
Inventory -------------------
Receivables ---------------536.80M611.60M598.80M619.20M
Total Liabilities --2.19B1.99B1.68B1.67B1.96B2.59B3.71B3.61B3.25B3.36B4.15B4.44B-3.77B3.81B3.69B3.81B
Current Liabilities --391.20M359.30M313.20M300.90M311.60M364.30M426.40M475.60M517.50M672.50M721.00M717.30M-575.90M656.40M841.00M836.40M
Long Term Debt --1.64B1.50B1.24B----------2.74B2.69B2.36B2.45B
Total Debt ---------------2.99B2.93B2.71B2.71B
Total Equity -1.46B-1.09B-897.60M-85.20M117.00M291.00M344.60M473.20M611.40M735.90M1.15B1.28B1.35B1.59B-1.31B1.65B2.07B2.44B
Shares Outstanding ---------------114.78M115.42M116.04M116.04M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 227.20M406.10M331.00M342.70M411.50M470.30M444.90M502.00M640.20M658.30M762.40M635.30M704.70M715.80M705.80M---
Investing Cash Flow -40.00M-133.00M-125.90M-24.60M-178.80M-226.20M-876.90M-1.13B-229.90M-283.00M-424.50M-657.40M-407.50M-666.30M-627.00M-602.80M-653.30M-764.60M
Financing Cash Flow -176.00M-224.30M-237.50M-336.30M-130.00M-312.40M434.20M622.70M-416.40M-359.90M-321.20M48.20M-145.90M-240.10M-145.70M-197.20M-330.60M-431.20M
Capital Expenditure -55.70M-63.30M-62.80M-100.30M-140.80M-195.20M-170.90M-128.40M-177.70M-225.80M-254.50M-372.40M-392.80M-524.60M-564.80M---
Free Cash Flow 171.50M342.80M268.20M242.40M270.70M275.10M274.00M373.60M462.50M432.50M507.90M262.90M311.90M191.20M141.00M---
Share Buybacks ---00234.10M43.10M45.30M65.60M38.10M045.90M6.10M00031.10M158.00M

Ratios (Annual)

Figures in %.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % ------------------
Operating Margin % --------16.1%14.8%13.0%13.3%15.8%13.9%12.4%---
Net Margin % --------6.8%6.9%6.8%7.8%8.0%10.3%6.2%7.3%8.5%9.5%
ROE % -23.2%-10.6%-1,055.2%178.4%63.6%93.9%46.9%29.9%33.6%23.5%22.9%26.5%17.9%-20.7%21.4%22.0%23.2%
ROCE % -------11.6%14.0%13.3%12.3%11.4%9.8%-10.7%---

Shareholding Pattern

Insiders
1.07%
Institutions
101.64%
Public Float
102.74%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for EHC

Yahoo Finance Wed, 05 Aug 2026

Encompass Health (EHC) Beats Q2 Earnings and Revenue Estimates

Encompass Health (EHC) delivered earnings and revenue surprises of +4.73% and +1.52%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Yahoo Finance Wed, 05 Aug 2026

Encompass Health (NYSE:EHC) Exceeds Q2 CY2026 Expectations, Stock Soars

Health care services provider Encompass Health (NYSE:EHC) announced better-than-expected revenue in Q2 CY2026, with sales up 9.6% year on year to $1.60 billion. The company expects the full year’s revenue to be around $6.45 billion, close t…

Yahoo Finance Wed, 05 Aug 2026

Encompass Health reports results for second quarter 2026

Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its results of operations for the second quarter ended June 30, 2026.…

Yahoo Finance Mon, 03 Aug 2026

Can Higher Occupancy Help Encompass Health Counter Rising Costs in Q2?

EHC's higher occupancy, rising discharges and hospital expansion could support Q2 growth, but can they offset mounting operating costs?

Yahoo Finance Mon, 03 Aug 2026

3 Healthcare Stocks With Fresh Dividend Hikes and Different Income Profiles

McKesson, Encompass Health and Omega Healthcare Investors raised dividends, with payout ratios and yields showing varying levels of sustainability across the healthcare sector.

Yahoo Finance Sat, 01 Aug 2026

Outpatient & Specialty Care Stocks Q1 Results: Benchmarking Encompass Health (NYSE:EHC)

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Encompass Health (NYSE:EHC) and the rest of the outpatient & specialty…

EHC — Frequently Asked Questions

What is the current share price of EHC?

As of 2026-08-05 17:25 PDT, EHC trades at $110.90 on NASDAQ/NYSE. Its 52-week range is $93.47 to $126.46.

What is the market capitalisation of EHC?

EHC has a market capitalisation of $12.87B on NASDAQ/NYSE.

What is the P/E ratio of EHC?

EHC trades at a trailing price-to-earnings (P/E) ratio of 20.02. Its price-to-book (P/B) ratio is 5.28.

What is the return on equity (ROE) of EHC?

EHC has a return on equity (ROE) of 23.22%. Its return on capital employed (ROCE) is 8.63%.

Is EHC a good stock to buy?

This page provides a data-driven analysis of EHC, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space